Virulence Factors as Potential Antigens for Serologic Tests

  • Slides: 21
Download presentation
Virulence Factors as Potential Antigens for Serologic Tests Horacio Bach, Ph. D. Division of

Virulence Factors as Potential Antigens for Serologic Tests Horacio Bach, Ph. D. Division of Infectious Diseases Department of Medicine University of British Columbia

Nature Review Microbiology 2: 189, 2004

Nature Review Microbiology 2: 189, 2004

ER = Endoplasmic reticulum LAM = Lipoarabinomannan PIM = Phosphatidylinositol mannoside TGN = Trans-Golgi

ER = Endoplasmic reticulum LAM = Lipoarabinomannan PIM = Phosphatidylinositol mannoside TGN = Trans-Golgi network Hestvik et al. , FEMS Microb. Rev 29: 1041, 2005

Virulence factors § Molecules secreted by the pathogen into the host § Block essential

Virulence factors § Molecules secreted by the pathogen into the host § Block essential pathways to allow survival § Produced de novo for new cell infection § Candidates to be processed in the lysosome and presented to antibody-producing cells

Virulence factors in MAP § Protein Phosphatase A § Protein Kinase G

Virulence factors in MAP § Protein Phosphatase A § Protein Kinase G

Protein Phosphorylation Systems Three systems in bacteria § Signal Transduction (modification of proteins) 1)

Protein Phosphorylation Systems Three systems in bacteria § Signal Transduction (modification of proteins) 1) “Two-component” system Predominant in prokaryotes Two proteins involved in signal transfer 2) Classical ATP/GTP-dependent system Predominant in eukaryotes O-kinases-phosphorylate OH groups of serine/threonine or tyrosine Formation of phosphomonoesters Dephosphorylated by specific O-phosphatases

Signal Transduction in Mycobacteria § 11 Two component system § 11 Eukaryotic serine-threonine kinases

Signal Transduction in Mycobacteria § 11 Two component system § 11 Eukaryotic serine-threonine kinases § 2 Protein tyrosine phosphatases (Ptp. A and Ptp. B § 1 Acid phosphatase (Sap. M)

Protein Phosphatase A Dephosphorylates the macrophage substrate VPS 33 B, leading to phagolysosome inhibition

Protein Phosphatase A Dephosphorylates the macrophage substrate VPS 33 B, leading to phagolysosome inhibition Bach et al. , Cell Host Microbe 3: 316, 2008

Protein Phosphatase A Prevents phagosome acidification Wong et al. , PNAS, 108: 19371, 2011

Protein Phosphatase A Prevents phagosome acidification Wong et al. , PNAS, 108: 19371, 2011

Protein Phosphatase A in MAP Live Map Ptp. A 24 h 48 h 72

Protein Phosphatase A in MAP Live Map Ptp. A 24 h 48 h 72 h Killed 24 h Bach et al. , Infection & Immunity 74: 6540, 2006

Protein Kinase G - Pkn. G • Soluble Ser/Thr kinase with endogenous and exogenous

Protein Kinase G - Pkn. G • Soluble Ser/Thr kinase with endogenous and exogenous activity • Secreted upon macrophage infection with BCG • Inhibit phago-lysosome fusion Walburger et al. , Science 304: 1800, 2004

Analysis of Ptp. A and Pkn. G in CD patients Caco-2 THP-1 MAP isolates

Analysis of Ptp. A and Pkn. G in CD patients Caco-2 THP-1 MAP isolates used were cow (squares), caprine (triangle), and rabbit (circle) Bach et al. , Scand J Gastro 46: 30, 2010

Analysis of Ptp. A and Pkn. G in CD patients Sample used: serum Frozen

Analysis of Ptp. A and Pkn. G in CD patients Sample used: serum Frozen same day Test: in-house ELISA control: recombinant protein Bach et al. , Scand J Gastro 46: 30, 2010

Analysis of Ptp. A and Pkn. G in CD patients CD Control Ptp. A

Analysis of Ptp. A and Pkn. G in CD patients CD Control Ptp. A 0. 174 0. 120 Pkn. G 0. 198 0. 135 Wilconox Rank Sum, p<0. 01 Bach et al. , Scand J Gastro 46: 30, 2010

a. Ptp. A antibodies in CD under treatment Xia et al. , Scand J

a. Ptp. A antibodies in CD under treatment Xia et al. , Scand J Gastro 49: 157, 2014

a. Ptp. A antibodies in CD under treatment Xia et al. , Scand J

a. Ptp. A antibodies in CD under treatment Xia et al. , Scand J Gastro 49: 157, 2014

a. Ptp. A antibodies in CD under treatment A = Azathioprine M = 5

a. Ptp. A antibodies in CD under treatment A = Azathioprine M = 5 -ASA S = Steroids Xia et al. , Scand J Gastro 49: 157, 2014

Antibodies against a-L 5 P • Major cell wall-associated lipid • Differs from MAA

Antibodies against a-L 5 P • Major cell wall-associated lipid • Differs from MAA Eckstein et al. JBC 281: 5209 2005

Antibodies against a-L 5 P Bacterium (Texas Red) MAP MAA a-L 5 P (FITC)

Antibodies against a-L 5 P Bacterium (Texas Red) MAP MAA a-L 5 P (FITC)

University of British Columbia Dr. Brian Bressler – Gastroenterology Dr. Yossef Av-Gay – Infectious

University of British Columbia Dr. Brian Bressler – Gastroenterology Dr. Yossef Av-Gay – Infectious Diseases Mount Sinai Hospital - Toronto Dr. Mark Silverberg – Gastroenterology Joanne Stempak– Gastroenterology INRA- France Dr. Jean Marc Reyrat Dr. Frank Biet Mc. Gill University Dr. Marcel Behr

THANK YOU FOR YOUR ATTENTION

THANK YOU FOR YOUR ATTENTION